主要文件

查看所有文档

J4205

JK184

Name: JK184
Brand: SIGMA

≥98% (HPLC), powder

别名:

N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolamine

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₉H₁₈N₄OS

化学文摘社编号:

315703-52-7

分子量:

350.44

UNSPSC Code:

51111800

PubChem Substance ID:

329815733

NACRES:

NA.77

Assay:

≥98% (HPLC)

Form:

powder

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

assay

≥98% (HPLC)

form

powder

color

off-white to light brown

solubility

DMSO: ≥20 mg/mL

storage temp.

room temp

SMILES string

CCOc1ccc(Cc2nc(cs2)-c3c(C)nc4ccccn34)cc1

InChI

1S/C20H19N3OS/c1-3-24-16-9-7-15(8-10-16)12-19-22-17(13-25-19)20-14(2)21-18-6-4-5-11-23(18)20/h4-11,13H,3,12H2,1-2H3

InChI key

CBKFVRMNQUKWPX-UHFFFAOYSA-N

说明

Biochem/physiol Actions

JK184 is a Hedgehog signaling pathway antagonist.

JK184 is a Hedgehog signaling pathway antagonist. JK184 blocks sonic hedgehog induced Gli transcription with an IC50 of 30 nM, and disrupts hedgehog signalling by inhibition of alcohol dehydrogenase 7 and depolymerization of mirotubules.

存储类别

11 - Combustible Solids

wgk

WGK 3

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

100M4709

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.

Helen O Oladapo et al.

Cancer letters, 411, 136-149 (2017-10-03)

Activation of the Hedgehog (Hh) pathway effector GLI1 is linked to tumorigenesis and invasiveness in a number of cancers, with targeting of GLI1 by small molecule antagonists shown to be effective. We profiled a collection of GLI antagonists possessing distinct

全球贸易项目编号

货号	GTIN
J4205-5MG	04061833219294
J4205-25MG	04061832271965